EPAC Stock Analysis: Enerpac Tool | NYSE
Specialty Industrial Machinery | NYSE, USA | Market Cap: 1.770m USD | 12M Return: -9.6% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 21.6M
EPS Trend: 91.3%
Qual. Beats: 1
Rev. Trend: 82.5%
Qual. Beats: 2
Warnings
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Enerpac Tool Group Corp. (EPAC) is a U.S.-based global manufacturer of high-force hydraulic and mechanical tools, cylinders, pumps, valves, bolt tensioners, and engineered heavy-lifting solutions, sold under brands including ENERPAC, HYDRATIGHT, LARZEP, DTA, and SIMPLEX. The company also provides related maintenance services and tool rentals, serving end markets such as infrastructure, industrial maintenance and repair, oil and gas, mining, renewable energy, and civil construction, with operations spanning North America, Europe, the Middle East, and Asia-Pacific. Originally incorporated in 1910 and headquartered in Milwaukee, Wisconsin, the business was formerly known as Actuant Corporation before adopting its current name in January 2020.
Within the Industrials sector, Enerpac operates in the Industrial Machinery & Supplies sub-industry, supplying specialized capital equipment and consumable tooling where switching costs and brand reputation are important competitive factors. Its combined model of product sales, aftermarket service, and tool rentals provides exposure to both project-driven demand from large infrastructure and energy customers and more recurring service revenue tied to maintenance cycles.
- Industrial tool demand tracks infrastructure and energy spending
- Heavy lifting technology segment expansion supports margins
- Acquisition strategy targets higher-margin branded portfolio growth
| Net Income: 93.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.14 > 0.02 and ΔFCF/TA 4.47 > 1.0 |
| NWC/Revenue: 35.37% < 20% (prev 41.20%; Δ -5.84% < -1%) |
| CFO/TA 0.15 > 3% & CFO 124.5m > Net Income 93.3m |
| Net Debt (69.1m) to EBITDA (150.7m): 0.46 < 3 |
| Current Ratio: 2.67 > 1.5 & < 3 |
| Outstanding Shares: last quarter (51.6m) vs 12m ago -5.24% < -2% |
| Gross Margin: 49.05% > 18% (prev 50.22%; Δ -1.17% > 0.5%) |
| Asset Turnover: 77.34% > 50% (prev 73.43%; Δ 3.91% > 0%) |
| Interest Coverage Ratio: 14.71 > 6 (EBIT TTM 132.6m / Interest Expense TTM 9.01m) |
| A: 0.28 (Total Current Assets 358.5m - Total Current Liabilities 134.3m) / Total Assets 811.5m |
| B: 0.33 (Retained Earnings 268.6m / Total Assets 811.5m) |
| C: 0.16 (EBIT TTM 132.6m / Avg Total Assets 819.8m) |
| D: 1.09 (Book Value of Equity 424.0m / Total Liabilities 387.5m) |
| Altman-Z'' = 5.13 = AAA |
| DSRI: 0.90 (Receivables 105.9m/113.2m, Revenue 634.1m/608.1m) |
| GMI: 1.02 (GM 50.22% / 49.05%) |
| AQI: 1.03 (AQ_t 0.49 / AQ_t-1 0.47) |
| SGI: 1.04 (Revenue 634.1m / 608.1m) |
| TATA: -0.04 (NI 93.3m - CFO 124.5m) / TA 811.5m) |
| Beneish M = -3.04 (Cap -4..+1) = AA |
As of July 28, 2026, the stock is trading at USD 34.88 with a total of 405,053 shares traded. Over the past week, the price has changed by +2.74%, over one month by -1.72%, over three months by -2.60% and over the past year by -9.57%.
Current recommended Stop Loss: 33.30 (which is 4.5% or 1.3 ATR below the current price).
Enerpac Tool has received a consensus analysts rating of 3.50. Therefore, it is recommended to hold EPAC.
- StrongBuy: 0
- Buy: 1
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 48 | 37.6% |
P/E Trailing = 19.7356
P/E Forward = 16.4745
P/S = 2.7914
P/B = 4.1752
P/EG = 0.3442
Revenue TTM = 634.1m USD
EBIT TTM = 132.6m USD
EBITDA TTM = 150.7m USD
Long Term Debt = 174.8m USD (from longTermDebt, last quarter)
Short Term Debt = 10.0m USD (from shortTermDebt, last quarter)
Debt = 184.8m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 69.1m USD (calculated: Debt 184.8m - CCE 115.7m)
Enterprise Value = 1.84b USD (1.77b + Debt 184.8m - CCE 115.7m)
Interest Coverage Ratio = 14.71 (Ebit TTM 132.6m / Interest Expense TTM 9.01m)
EV/FCF = 16.38x (Enterprise Value 1.84b / FCF TTM 112.3m)
FCF Yield = 6.11% (FCF TTM 112.3m / Enterprise Value 1.84b)
FCF Margin = 17.71% (FCF TTM 112.3m / Revenue TTM 634.1m)
Net Margin = 14.72% (Net Income TTM 93.3m / Revenue TTM 634.1m)
Gross Margin = 49.05% ((Revenue TTM 634.1m - Cost of Revenue TTM 323.1m) / Revenue TTM)
Gross Margin QoQ = 52.04% (prev 45.44%)
Tobins Q-Ratio = 2.27 (Enterprise Value 1.84b / Total Assets 811.5m)
Interest Expense / Debt = 4.88% (Interest Expense 9.01m / Debt 184.8m)
Taxrate = 24.24% (29.9m / 123.2m)
NOPAT = 100.5m (EBIT 132.6m * (1 - 24.24%))
Current Ratio = 2.67 (Total Current Assets 358.5m / Total Current Liabilities 134.3m)
Debt / Equity = 0.44 (Debt 184.8m / totalStockholderEquity, last quarter 424.0m)
Debt / EBITDA = 0.46 (Net Debt 69.1m / EBITDA 150.7m)
Debt / FCF = 0.62 (Net Debt 69.1m / FCF TTM 112.3m)
Total Stockholder Equity = 424.1m (last 4 quarters mean from totalStockholderEquity)
RoA = 11.38% (Net Income 93.3m / Total Assets 811.5m)
RoE = 22.00% (Net Income TTM 93.3m / Total Stockholder Equity 424.1m)
RoCE = 22.14% (EBIT 132.6m / Capital Employed (Equity 424.1m + L.T.Debt 174.8m))
RoIC = 15.32% (NOPAT 100.5m / Invested Capital 655.6m)
WACC = 7.97% (E(1.77b)/V(1.95b) * Re(8.42%) + D(184.8m)/V(1.95b) * Rd(4.88%) * (1-Tc(0.24)))
Discount Rate = 8.42% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -87.11 | Cagr: -2.57%
[DCF] Terminal Value 77.97% ; FCFF base≈98.4m ; Y1≈112.8m ; Y5≈166.0m
[DCF] Fair Price = 47.13 (EV 2.50b - Net Debt 69.1m = Equity 2.43b / Shares 51.5m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 91.30 | EPS CAGR: 10.41% | SUE: 4.0 | # QB: 1
Revenue Correlation: 82.49 | Revenue CAGR: 2.16% | SUE: 0.98 | # QB: 2
EPS current Quarter (2026-11-30): EPS=0.41 | Chg30d=-1.19% | Revisions=+0% | Analysts=2
EPS current Year (2026-08-31): EPS=1.86 | Chg30d=-1.49% | Revisions=-29% | GrowthEPS=+3.0% | GrowthRev=+3.7%
EPS next Year (2027-08-31): EPS=2.06 | Chg30d=-5.50% | Revisions=+29% | GrowthEPS=+10.5% | GrowthRev=+4.9%
[Analyst] Revisions Ratio: +0% (up=5, down=5)